SHERYL CROW AND GWEN STEFANI JOIN ALL-STAR LINE UP TO HONOR EDGAR BRONFMAN, JR. AND RAISE FUNDS FOR THE CITY OF HOPE
- Artists To Perform Classic Motown Music -
Santa Monica, California, October 4, 2001 – Sheryl Crow and Gwen Stefani have been added to the line-up of top artists who will be interpreting classic Motown songs as part of this year’s City of Hope Spirit of Life Award dinner honoring Vivendi Universal Executive Vice Chairman Edgar Bronfman, Jr. Proceeds from the event, held October 11th on the Universal Studios backlot, will establish an honorary research fellowship in Mr. Bronfman’s honor at the City of Hope National Medical Center and Beckman Research Institute.
Other artists already announced are India.Arie, Bilal, Mary J. Blige, Jon Bon Jovi, Roger Daltrey, Melissa Etheridge, Vince Gill, Amy Grant, Ronan Keating, Jonny Lang, Shelby Lynne, Smokey Robinson, Richie Sambora, Sisqo, and The Temptations along with special guests to be announced.
“This is an incredible honor for me,” comments Mr. Bronfman. “I am pleased that we will be able to help raise funds for The City of Hope, which continues to lead the charge in aiding people throughout the country who are struggling with cancer and other life-threatening diseases. I am also honored by the level of world-class talent that will be joining us to make this evening possible.”
The music and entertainment industry has raised more than $30 million for the City of Hope in its 27-year history.
Edgar Bronfman, Jr. is Executive Vice Chairman of Vivendi Universal, a leading global media and communications company. Formed in December 2000 as the result of the merger between Vivendi, Seagram and Canal Plus, Vivendi Universal operates five core communications units, including Music, Publishing, TV and Film, Telecoms and Internet. Its environmental unit, Vivendi Environnement, is the worldwide leader in environmental services.
Among those five core businesses, Universal Music Group is the world's leading music company with such renowned labels as Decca Record Company, Deutsche Grammophon, Interscope Geffen A&M Records, Island Def Jam Music Group, Hip-O, Lost Highway Records, MCA Nashville, MCA Records, Mercury Records, Motown Records, Philips, Polydor, Universal Records, and Verve Music Group. Its businesses also include Universal Music Publishing Group, one of the industry’s largest global music publishing operations.
Prior to the December 2000 formation of Vivendi Universal, Mr. Bronfman was President and Chief Executive Officer of The Seagram Company Ltd., a post he held since June 1994. He held the same title with Joseph E. Seagram & Sons, Inc., the Corporation's U.S. subsidiary. Mr. Bronfman was elected to Seagram’s Board of Directors in May 1988 and was a member of its Executive Committee.
Under Mr. Bronfman’s leadership at Seagram, the spirits and wine company transformed into a leading global media and communications company. As the company’s President and CEO, Mr. Bronfman engineered transactions totaling more than $80 billion. In addition to its premier spirits and wine business, Seagram’s assets had included Universal Music Group and Universal Studios, which includes Universal Pictures and Universal Studios theme parks.
Mr. Bronfman joined Seagram in 1982 as Assistant to the Office of the President of The Seagram Company Ltd. and Joseph E. Seagram & Sons, Inc. and, throughout his career, he held numerous increasingly responsible executive positions.
Mr. Bronfman is a member of the Boards of USA Networks, Inc., New York University Medical Center, The Wharton School of the University of Pennsylvania, and the Board of Governors of The Joseph H. Lauder Institute of Management & International Studies at the University of Pennsylvania. Mr. Bronfman is married and resides in New York City. He has seven children.
City of Hope National Medical Center and Beckman Research Institute is a premier research and treatment center for cancer and other serious diseases including diabetes and HIV/AIDS located in the greater Los Angeles area. One of only 40 National Cancer Institute-designated Comprehensive Cancer Centers, City of Hope continues to be in the top five percent of institutions receiving National Institutes of Health funding awards. Throughout the organization’s history, pioneering treatments have been perfected because of the talented physicians and researchers at City of Hope. Two of the four new drugs that have revolutionized cancer care across the globe, Herceptin® and Rituxan®, are the direct result of research efforts at City of Hope.
In addition, discoveries such as the creation of the first genetically engineered healthcare product approved for use by the FDA, Humulin®—a synthetic form of human insulin used by millions of people with diabetes—are characteristic of City of Hope’s commitment to excellence, health and a life free of disease. The work conducted at City of Hope is shared with medical centers worldwide, touching the lives of millions of people everywhere.
For more information about how you can support City of Hope’s lifesaving research and treatment programs, please call 800-260-HOPE, or visit the Web site at www.cityofhope.org.
City of Hope—Where the Power of Knowledge Saves Lives™